Answer
Yes, diarrhoea and/or vomiting during lomitapide mesylate (Lojuxta) treatment may reduce the effectiveness of oestrogen-based oral contraceptives, and patients should be advised about this possibility.
Sources for this answer
- Lojuxta 5mg hard capsulesChiesi Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 6Document updated
Sources checked